军事知识服务平台
高糖驱动血管平滑肌细胞病理重塑机制及干预进展
Research progress in mechanisms and interventions of high glucose-driven pathological remodeling of vascular smooth muscle cells
摘要 糖尿病大血管并发症是导致患者死亡和残疾的重要原因,高糖是其发生发展的关键病理因素.血管平滑肌细胞(vascular smooth muscle cells,VSMCs)作为血管壁中膜的主要结构成分,在维持血管壁结构完整性和血管张力调节中发挥关键作用,也是糖尿病性血管重塑的重要效应细胞.近年研究发现,高糖刺激可通过诱导表型转化、代谢重编程、氧化应激、炎症反应、自噬失衡以及衰老和钙化等一系列变化,持续推动VSMCs功能紊乱和血管病理重塑.该文围绕"高糖驱动VSMCs病理重塑"这一主线,对相关研究进展进行系统梳理,重点综述高糖诱导VSMCs表型转化的关键分子机制、非编码RNA及表观遗传调控网络、氧化应激—炎症—自噬耦联通路,以及这些过程在细胞外基质重塑、细胞衰老和血管钙化中的作用.在此基础上,总结了降糖药物、天然产物和分子靶向干预的研究进展,以期为高糖相关血管损伤的防治提供理论依据和潜在干预靶点.
Abstract:
Diabetic macrovascular complications are a leading cause of death and disability,and hyperglycemia is a key patho-logical factor driving their onset and progression.Vascular smooth muscle cells(VSMCs),as the main structural component of the tunica media,play a critical role in maintaining vascular wall integrity and regulating vascular tone,and are also important effector cells in diabetes-induced vascular remodeling.Recent studies have revealed that high glucose stimulation continuously promotes VSMCs dysfunction and pathological vascular remodeling through a series of changes,including phenotypic switching,metabolic reprogramming,oxidative stress,inflammatory responses,autophagic imbalance,as well as senescence and calcifica-tion.Focusing on the main theme of"hyperglycemia-driven pathological remodeling of VSMCs",this article systematically re-views relevant research advances,with an emphasis on the key molecular mechanisms underlying high glucose-induced VSMCs phenotypic switching,the regulatory networks of non-coding RNAs and epigenetics,the coupled oxidative stress-inflammation-autophagy pathways,and the roles of these processes in extracellular matrix remodeling,cellular senescence,and vascular cal-cification.On this basis,we further summarize the research progress of glucose-lowering drugs,natural products,and molecular targeted therapies,aiming to provide a theoretical basis and potential intervention targets for the prevention and treatment of hy-perglycemia-related vascular injury.
刊 名 生物技术
年,卷(期): 2026, 36(3)
分类号: R587.1 R543
机标分类号: R244.1 R587.1 R730.21
在线出版日期: 2026年8月6日
基金项目: 31870771:国家自然科学基金,